Intravitreal Aflibercept for Diabetic Macular Edema-Reference-Cited by-同舟云学术

Intravitreal Aflibercept for Diabetic Macular Edema

Published:2015-10 Issue:10 Volume:122 Page:2044-2052
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Brown David M.,Schmidt-Erfurth Ursula,Do Diana V.,Holz Frank G.,Boyer David S.,Midena Edoardo,Heier Jeffrey S.,Terasaki Hiroko,Kaiser Peter K.,Marcus Dennis M.,Nguyen Quan D.,Jaffe Glenn J.,Slakter Jason S.,Simader Christian,Soo Yuhwen^ORCID,Schmelter Thomas,Yancopoulos George D.,Stahl Neil,Vitti Robert,Berliner Alyson J.,Zeitz Oliver,Metzig Carola,Korobelnik Jean-François

Publisher

Elsevier BV

Subject

Ophthalmology

Reference31 articles.

1. Anti-vascular endothelial growth factor therapy for diabetic macular edema;Boyer;Ther Adv Endocrinol Metab,2013

2. International Diabetes Foundation. IDF Diabetes Atlas. Available at: http://www.idf.org/diabetesatlas. Accessed November 20, 2014.

3. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010;Bourne;Br J Ophthalmol,2014

4. Visual impairment and blindness in Europe and their prevention;Kocur;Br J Ophthalmol,2002

5. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies;Ciulla;Diabetes Care,2003

Cited by 454 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema;JAMA Ophthalmology;2024-09-12

2. Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability;Expert Opinion on Drug Metabolism & Toxicology;2024-09-11

3. Optical coherence tomography angiography for microaneurysms in anti-vascular endothelial growth factor treated diabetic macular edema;BMC Ophthalmology;2024-09-09

4. One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity;Ophthalmology Retina;2024-09

5. Identification of Potential Inhibitors from Medicinal Plant-based Phytochemicals for the Influential C4 Target of Diabetic Retinopathy by Molecular Docking Studies;Current Pharmaceutical Design;2024-08-08